Why the study?
Catheter ablation of ventricular arrhythmias arising from the left ventricle papillary muscles is clinically challenging.
Does catheter ablation using contact force sensing RF with ICE or cryoablation with CT integration reduce ventricular arrhythmia recurrence compared to non-contact force sensing RF in patients with papillary muscle arrhythmias?
Does catheter ablation using contact force sensing RF with ICE or cryoablation with CT integration reduce ventricular arrhythmia recurrence compared to non-contact force sensing RF in patients with papillary muscle arrhythmias?
In patients with ventricular arrhythmias from LV papillary muscles, ablation using contact force sensing RF with ICE or cryoablation with CT integration yields higher acute success and lower 12-month recurrence than non-contact force sensing RF.
Image-guided multi-energy ablation appears feasible for PM VAs; leaves open optimal technique and durability in prospective studies.
Background Catheter ablation of ventricular arrhythmias (VAs) arising from the left ventricle`s (LV) papillary muscles (PM) is challenging. In this study we present results of catheter ablation using multiple energy sources and image‐based approaches. Methods Fifty‐three patients (49 ± 17 years old; 34% females; median LV ejection fraction 53 ± 11%) underwent catheter cryoablation or radiofrequency (RF) ablation with non‐contact force sensing (Non‐CFS) catheters and cardiac computed tomography integration (CTII) into the electroanatomical mapping system or contact force sensing RF (CFS RF) ablation catheters and intracardiac echo‐facilitated 3D electroanatomical mapping. Ventricular arrhythmias foci were mapped at either the anterolateral (ALPM) or posteromedial papillary muscles (PMPM). Ablation was performed using an 8‐mm cryoablation catheter (CRYO); a Non‐CFS 4‐mm open‐irrigated RF catheter; or a CFS RF 3.5‐mm open‐irrigated tip catheter, via transmitral or transaortic approach. Results Acute success rate was 83% for Non‐CFS RF/CTII; 100% for CRYO/CTII (n = 16) and CFS RF/ICE3D (n = 14) ( P = 0.03). Catheter stability was achieved in all patients treated with Cryo/CTII. VA recurrence at 12 months follow‐up was 48% (n = 11) for Non‐CFS RF/CTII; 19% (n = 3) for CRYO/CTII; and 7% (n = 1) for CFS RF/ICE3D ( P = 0.02). Conclusions Non‐CFS/CTII was associated with an increased risk of recurrence of the clinical arrhythmia. Ablation with either CFS RF/ICE3D or CRYO/CTII showed high acute success rates and low recurrence rates during follow‐up. Cryoablation provided stable contact and was less arrhythmogenic.
No takes yet. Share an insight, caveat, or question.
Rivera et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: